EQS-News: PAION AG / Key word(s): Regulatory ApprovalPAION receives UK MHRA approval of Byfavo® (remimazolam) for the induction and maintenance of general anesthesia in adults 31.08.2023 / 14:00 CET/CESTThe issuer is solely responsible for the content of this announcement.PAION receives UK MHRA approval of Byfavo® (.
EQS-News: PAION AG / Key word(s): Half Year ResultsPAION AG reports financial results for the First Half-Year 2023 30.08.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.PAION AG reports financial results for the First Half-Year 2023 Byfavo® approval by European Commi.
EQS-News: PAION AG / Key word: Product Launch
PAION launches Byfavo® in the first European country for General Anesthesia
22.08.2023 / 14:00 CET/CEST
The.